Bloomberg SoftBank Group Corp. is nearing a deal to invest about $400 million in Ping An Insurance (Group) Co.’s health-care portal ahead of the Chinese company’s initial public offering, people with knowledge of the matter said. The Ping An unit, known as Good Doctor, aims to file an IPO application with the Hong Kong stock exchange as soon as the ...
Read More »Admin
‘M&A hunt to drive India’s offshore bonds rush in 2018’
Bloomberg Offshore bonds volumes from India are set to gather pace after a banner year as companies tap the lowest borrowing costs in a decade to pay for buying assets locally and abroad. That’s the view of Citigroup Inc., which forecasts sales of debt denominated in US dollar, euro and yen in 2018 to be as good as last year ...
Read More »â€˜Foreign labour in Singapore is more than just numbers’
Bloomberg Singapore should remain open to adjusting levels of foreign workers while not threatening job and wage opportunities for native residents, Monetary Authority of Singapore Managing Director Ravi Menon said. “It is not about how many foreign workers industry wants or society can afford to have, but what number and kind of foreign workers we need to maximise the job ...
Read More »Top Indian oil explorer plans to raise $5.48bn to buy HPCL
Bloomberg India’s biggest oil and gas explorer has widened its first debt-raising plan to as much as $5.48 billion to buy state-run refiner Hindustan Petroleum Corp. Oil & Natural Gas Corp’s board has approved raising as much as 350 billion rupees in loans to buy the government’s 51.1 percent stake in HPCL, Chairman Shashi Shanker said in New Delhi. That ...
Read More »Iraq, Orion sign deal on natural gas processing
BAGHDAD / Reuters Iraq agreed a deal with US energy company Orion on Monday to process natural gas extracted at its giant Nahr Bin Omar oilfield. The memorandum of understanding, signed in Baghdad by representatives of the oil ministry and the US company, will allow Orion Gas Processors to build facilities to capture the gas from the field located in ...
Read More »Libyans ditch dollars as crude recovery offers economic relief
Bloomberg Libya’s powerful black market traders are encountering an unfamiliar sight: people showing up with bundles of dollars for sale. Rising oil prices have relieved financial pressure on Libya, allowing authorities to channel more dollars to importers since the start of the year. Meanwhile, the central bank has eased restrictions on currency transfers that had made the black market the ...
Read More »Oil holds near $69 as nations say output cuts will continue
Bloomberg Brent crude steadied after Saudi Arabia and Russia pledged to continue supply cuts. Futures rose as much as 0.5 percent in London before paring those gains. Output limits should remain through 2018 as rebalancing may be achieved next year, Saudi Arabia’s Energy Minister Khalid Al-Falih said in a Bloomberg television interview held with his Russian counterpart. Russia is prepared ...
Read More »Biggest US east coast oil refinery files for bankruptcy
Bloomberg Philadelphia Energy Solutions LLC, owner of the largest oil refinery serving the New York Harbor gasoline and diesel market, filed for Chapter 11 bankruptcy protection. The company, a joint-venture between The Carlyle Group LP and a subsidiary of Energy Transfer Partners LP, filed a petition in US Bankruptcy Court in Delaware. Chief Executive Greg Gatta said in a memo ...
Read More »Saudi seeks proposals to refinance $10bn loan
DUBAI / Reuters Saudi Arabia has asked banks for proposals to refinance its $10 billion international syndicated loan and to help the sovereign raise funds through other means, the country’s debt management office said. In addition to the req- uest for proposals (RFP) on the loan refinancing, the government has issued RFPs covering further US dol- lar debt capital market ...
Read More »Sanofi buys US haemophilia drugmaker for $11.6 billion
Bloomberg Sanofi SA agreed to buy Bioverativ Inc., a spinoff from biotech giant Biogen Inc., for about $11.6 billion in a bid by France’s biggest drugmaker to gain treatments for rare blood disorders. The deal values haemophilia drugmaker Bioverativ at $105 a share, according to a statement from Sanofi. Sanofi shares fell 2.6 percent to 71.05 euros at 9:18 am ...
Read More »